Philip Tsai's most recent trade in Immunome Inc was a trade of 12,300 Common Stock done at an average price of $8.4 . Disclosure was reported to the exchange on March 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Philip Tsai | Chief Technology Officer | Purchase of securities on an exchange or from another person at price $ 8.42 per share. | 24 Mar 2025 | 12,300 | 33,300 | - | 8.4 | 103,566 | Common Stock |
| Immunome Inc | Philip Tsai | Chief Technology Officer | 21 Nov 2024 | 21,000 | 21,000 | - | 9.4 | 198,030 | Common Stock | |
| Immunome Inc | Philip Tsai | Chief Technology Officer | 17 Jun 2024 | 250,000 | 250,000 | - | - | Stock option (right to buy) |